0001404644-24-000010.txt : 20240314
0001404644-24-000010.hdr.sgml : 20240314
20240314205455
ACCESSION NUMBER: 0001404644-24-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240314
DATE AS OF CHANGE: 20240314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMinn Rachel
CENTRAL INDEX KEY: 0001606302
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 24752217
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 450 W. 15TH ST., STE. 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neurogene Inc.
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980542593
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 W 24TH STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: (877) 237-5020
MAIL ADDRESS:
STREET 1: 535 W 24TH STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc.
DATE OF NAME CHANGE: 20190812
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
DATE OF NAME CHANGE: 20140128
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
4
1
wk-form4_1710464082.xml
FORM 4
X0508
4
2024-03-13
0
0001404644
Neurogene Inc.
NGNE
0001606302
McMinn Rachel
C/O NEUROGENE INC.
535 W 24TH STREET, 5TH FLOOR
NEW YORK
NY
10011
1
1
0
0
Chief Executive Officer
0
Employee Stock Option (Right to buy)
36.06
2024-03-13
4
A
0
93282
0
A
2034-03-13
Common Stock
93282
93282
D
The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.
/s/ Christine Mikail, as attorney-in-fact for Rachel McMinn
2024-03-14